Table 2:
Routes with the highest variations among BRCA, COAD, and STAD cohorts
ID | Route (p1 - Signaling route, p2 - Effector Route) | BRCA | COAD | STAD | |||
---|---|---|---|---|---|---|---|
| |||||||
PS | ARS | PS | ARS | PS | ARS | ||
9 | Adipocytokine signaling pathway(p1) LEP, LEPR, PPARA, RXRA, RXRB, RXRG | 0.99 | −0.97 | 0.1 | −0.38 | 0.1 | −0.35 |
176 | IL-17 signaling pathway(p2) FOS, FOSB, JUN, JUND, FOSL1, IL6 | 0.89 | −0.84 | 0.14 | 0.22 | 0.73 | −0.65 |
460 | Toll-like receptor signaling pathway(p2) FOS, JUN, IL12A, IL12B, TNF, IL1B, IL6 | 0.81 | −0.41 | 0.16 | 0 | 0.66 | −0.34 |
110 | ErbB signaling pathway(p1) EGF, TGFA, AREG, EGFR, ERBB2, STAT5A, STAT5B | 0.74 | −0.73 | 0.17 | −0.21 | 0.1 | 0.06 |
424 | Thyroid hormone signaling pathway(p2) THRA, MYH6, MYH7, ATP2A2, ATP2A1, ATP2A3, PLN | 0.78 | −0.47 | 0.23 | −0.32 | 0.14 | −0.23 |
434 | Tight junction(p2) YBX3, CDK4, SYMPK, CCND1 | 0.08 | 0.25 | 0.72 | 0.91 | 0.17 | 0.46 |
299 | PPAR signaling pathway(p2) PPARG, RXRA, RXRB, RXRG, SCD5, SCD, FADS2, ME1, ME3 | 0.69 | −0.3 | 0 | 0.22 | 0.11 | 0.04 |
400 | Th17 cell differentiation(p2) MAPK14, MAPK11, MAPK13, MAPK12, IRF4 | 0.05 | −0.11 | 0.66 | −0.57 | 0.48 | −0.44 |
432 | Tight junction(p2) JUN, CD1A, CD1B, CD1C, CD1D, CD1E | 0.59 | −0.54 | 0.1 | 0.07 | 0.63 | −0.6 |
472 | Wnt signaling pathway(p2) TCF7, TCF7L1, TCF7L2, TCF4, LEF1, FOSL1, JUN, MYC, MMP7, PPARD, WISP1, CCND1, CCND2, CCND3, Cell cycle | 0.12 | −0.06 | 0.41 | 0.25 | 0.13 | 0.05 |